PATENT CLAIM ANALYSIS

Application Number: 16108964
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["544", "106000"]

Abstract:
Embodiments of the disclosure relate to selectively substituted quinolone compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.

Claim (Index 19):
The method of  claim 10 , wherein the method is used for treatment of systemic lupus erythematosus or lupus nephritis.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 96.0
- Lexical Diversity: 1.10256
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14513556', '15670904', '14908164', '14806174', '13907202']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8908581424438072
- 35 USC 102 Novelty (BERT): 0.5824770265417339
- Combined Prediction Score: 0.8600200308535999
- Mean Citation Score: 577.5672900000002
- Max Citation Score: 622.8006
- Similarity Product: 410.6927482860804

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test